Hangzhou Alltest Biotech Co., Ltd. (SHA:688606)
China
· Delayed Price · Currency is CNY 65.48
-0.43 (-0.65%)
Mar 9, 2026, 3:00 PM CST
Hangzhou Alltest Biotech Revenue
In the year 2025, Hangzhou Alltest Biotech had annual revenue of 911.30M CNY with 5.16% growth. Hangzhou Alltest Biotech had revenue of 278.22M in the quarter ending December 31, 2025, with 11.94% growth.
Revenue
911.30M
Revenue Growth
+5.16%
P/S Ratio
5.63
Revenue / Employee
940.45K
Employees
960
Market Cap
5.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 911.30M | 44.72M | 5.16% |
| Dec 31, 2024 | 866.58M | 111.89M | 14.83% |
| Dec 31, 2023 | 754.70M | -2.63B | -77.73% |
| Dec 31, 2022 | 3.39B | 1.52B | 80.88% |
| Dec 31, 2021 | 1.87B | 737.87M | 64.98% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangxi Sanxin Medtec | 1.59B |
| Zhonghong Pulin Medical Products | 2.48B |
| SWS Hemodialysis Care | 806.82M |
| Qingdao NovelBeam Technology | 602.61M |
| Chimin Health Management | 637.78M |
| Well Lead Medical | 1.64B |
| Jiangsu Apon Medical Technology | 380.70M |
| QITIAN Technology Group | 463.35M |